# US 2024/0174588 A1 · Method for preparing chiral alkyl compounds by asymmetric hydrogenation of olefins catalyzed by iron complex

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0174588 A1
- Document ID: US20240174588A1
- Status: Published application
- Kind: A1
- Application number: 18/210,771
- Filed: 2023-06-16
- Published: 2024-05-30
- Earliest claimed: 2021-01-22
- Assignees: Zhejiang University
- Applicants: Zhejiang University
- Inventors: Zhan Lu; Peng Lu; Xiang Ren
- Web page: https://patentgrep.com/patent/US20240174588A1

## CPC

- C07C 41/20: by hydrogenation of carbon-to-carbon double or triple bonds
- B01J 31/0248: {Nitriles}
- B01J 31/0274: {containing silicon (ligands in coordination complexes B01J31/1608)}
- B01J 31/12: containing organo-metallic compounds or metal hydrides
- B01J 31/146: {of boron}
- B01J 31/182: {comprising aliphatic or saturated rings}
- B01J 31/1835: {comprising aliphatic or saturated rings}
- C07B 35/02: Reduction
- C07B 53/00: Asymmetric syntheses
- C07C 5/03: of non-aromatic carbon-to-carbon double bonds
- C07C 17/354: by hydrogenation
- C07C 37/003: {by hydrogenation of an unsaturated part}
- C07C 37/055: the substituted group being bound to oxygen, e.g. ether group
- C07C 209/70: by reduction of unsaturated amines
- C07D 209/08: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C07D 317/22: etherified
- C07D 317/50: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- B01J 31/2217: {At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand}
- B01J 2231/645: of C=C or C-C triple bonds
- B01J 2531/0244: Pincer-type complexes, i.e. consisting of a tridentate skeleton bound to a metal, e.g. by one to three metal-carbon sigma-bonds
- B01J 2531/842: Iron
- C07C 2531/22: Organic complexes
- C07C 2602/12: the other ring being at least seven-membered
- C07C 2602/42: the bicyclo ring system containing seven carbon atoms
- C07C 2603/68: Dicyclopentadienes; Hydrogenated dicyclopentadienes
- C07F 15/025: {without a metal-carbon linkage}
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

Provided in the present invention is a method for preparing chiral alkyl compounds by the asymmetric hydrogenation reaction of iron complex catalysts catalysing olefins: using the disubstituted olefin shown in formula I as a raw material, atmospheric hydrogen as a hydrogen source, FeX2-8-OIQ complex as a catalyst, and a silane compound and acetonitrile as cocatalysts, and reacting for 12-24 hours under the action of a reducing agent to prepare the chiral alkyl compound shown in formula II. The method of the present invention has mild reaction conditions, simple operation, and high atom economy. In addition, the reaction does not require the addition of any other toxic transition metal (such as ruthenium, rhodium, and palladium), and has great practical application value in the synthesis of drugs and materials. The conversion rate of the reaction is also good, generally reaching >99%, and the enantioselectivity is also high, generally 70-99%.

## Claims

### Claim 1

A method for preparing chiral alkyl compounds by asymmetric hydrogenation of olefins catalyzed by iron complex catalyst, wherein the method is as follows: a disubstituted olefin shown in Formula I is used as a raw material, atmospheric hydrogen is used as hydrogen source, FeX2-8-OIQ complex is used as catalyst, hydrosilane and acetonitrile are used as co catalysts, and a chiral alkyl compound shown in Formula II is prepared by reaction for 12-24 hours under the activation of a reducing agent;
in Formula II, * represents a chiral carbon atom;
in Formula I or Formula II, R1 is C2˜C8 alkyl, naphthyl, a group shown in Formula III, or a N and O containing heterocyclic aryl group of C4˜C10;
in R1, the H on C2˜C8 alkyl is not substituted or substituted by at least one substituent A, and the substituent A is phenyl, naphthyl, heterocyclic aryl or substituted phenyl; heterocyclic aryl is indolyl, pyridinyl, pyrrolyl, thiophenyl or furanyl; substituted phenyl is the phenyl group in which H on phenyl is replaced by at least one substituent B, and the substituent B is C1˜C3 alkylp, C1˜C3 alkoxy, halogen or C1˜C3 alkylthio;
in R1, the N and O containing heterocyclic aryl group of C4˜C10 is pyridinyl, pyrrolyl, indolyl, benzodioxazolyl, benzoxazolyl or furanyl;
in R1, the H on naphthyl and the N and O containing heterocyclic aryl group of C4˜C10 are not substituted or substituted by at least one substituent C, and the substituent C is C1˜C3 alkyl or C1˜C3 alkoxy;
in R1, among the groups shown in Formula III, R4, R5, R6, R7, R8 are selected from any one of H, halogen, C1˜C3 alkyl, C1˜C3 alkoxy, benzyloxy, C1˜C3 alkylthio, tert butyl dimethyl siloxy, trifluoromethyl, dimethylamino, pinacol borate, d-borneoxy, citronellol oxy, menthol oxy or geraniol oxy, and when R4, R5, R6, R7, R8 are all H, Formula III is phenyl; and halogen is F or Cl;
in Formula I or Formula II, R2 is C1˜C8 alkyl, C2˜C8 alkenyl, phenyl or benzyl; the H on C1˜C8 alkyl and C2˜C8 alkenyl are not substituted or substituted by at least one substituent D, which is phenyl, substituted phenyl, C1˜C3 amino or 1,3-dioxolacyl;
or in Formula I or Formula II, R1 and R2 are connected into a ring to form C9˜C12 benzocycloalkyl; H on C9˜C12 benzocycloalkyl is not substituted or substituted by at least one substituent E, and the substituent E is C1˜C3 alkyl, C1˜C3 alkoxy or halogen;
R1 and R2 are different substituents.

### Claim 2 (depends on 1)

The method according to claim 1, wherein R1 is C2˜C8 alkyl, naphthyl, 6-methoxynaphthalyl, pyridinyl, 2-methoxypyridyl, indolyl, N-methylindolyl, benzodioxazolyl or the group shown in Formula III;
in R1, when R1 is C2˜C8 alkyl, H on C2˜C8 alkyl is replaced by a substituent A, R1 is expressed as RA—(CH2)n—, wherein n is an integer of 2 to 8, RA is a substituent A on the carbon chain, and RA is phenyl, naphthyl or p-methoxyphenyl;
the group shown in Formula III is phenyl or substituted phenyl with 1-2 substituents, and the substituent on the substituted phenyl is halogen, C1˜C2 alkyl, C1˜C3 alkoxy, benzyloxy, C1˜C3 alkylthio, tert-butyl dimethyl siloxy, trifluoromethyl, dimethylamino, pinacol borate, d-borneol, citronellol-oxyl, menthol-oxyl or geraniol-oxyl;
R2 is C2˜C6 alkyl, C2˜C6 alkenyl, phenyl or benzyl; H on the C2˜C6 alkyl is not substituted or substituted by substituent D, R2 is C2˜C6 alkyl, and when H on the alkyl is substituted by substituent D, R2 is expressed as RD—(CH2)m—, m is an integer of 2 to 6, and the substituent D is phenyl, C1˜C3 amino, 4-methoxyphenyl or 1,3-dioxolacyl.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the catalyst FeX2-8-OIQ complex is an optically pure compound shown in Formula IV or its enantiomer or racemate;
in Formula IV, R9 is C1˜C12 alkyl which is unsubstituted or substituted by 1 or 2 C1˜C4 alkoxy, C5˜C12 cycloalkyl which is unsubstituted or substituted by 1-3 substituents a, or aryl a which is unsubstituted or substituted by 1-4 substituents b; the aryl a is benzyl, phenyl or naphthyl; the substituent a is C1˜C4 alkyl or C1˜C4 alkoxy; and the substituent b is C1˜C4 alkyl, C1˜C4 alkoxy, C1˜C4 fluoroalkyl, C1˜C4 fluoroalkoxy, F or Cl;
R10 is H, C1˜C12 alkyl which is unsubstituted or substituted by 1-2 C1˜C4 alkoxy, C5˜C12 cycloalkyl which is unsubstituted or substituted by 1-3 substituents a, or aryl b which is unsubstituted or substituted by 1-3 substituents b; the aryl b is phenyl or naphthyl; the substituent a is C1˜C4 alkyl or C1˜C4 alkoxy; and the substituent b is C1˜C4 alkyl, C1˜C4 alkoxy, C1˜C4 fluoroalkyl, C1˜C4 fluoroalkoxy, F or Cl;
R11; R12, R13, R14 and R15 are independently H, C1˜C12 alkyl, C1˜C4 fluoroalkoxy, F, Cl, nitro or C5˜C12 cycloalkyl which is unsubstituted or substituted by 1-3 substituents a;
R16 and R17 are independently H, C1˜C12 alkyl which is unsubstituted or substituted by 1-2 C1˜C4 alkoxy, C5˜C12 cycloalkyl which is unsubstituted or substituted by 1-3 substituents a, or aryl a which is unsubstituted or substituted by 1-3 substituents b;
R18 is a C1˜C12 alkyl group that is not substituted or substituted by 1-2 C1˜C4 alkoxy, C5˜C12 cycloalkyl which is not substituted or substituted by 1-3 substituents a, or aryl a which is not substituted or substituted by 1-3 substituents b;
in Formula IV, * represents a chiral carbon atom;
X is F, Cl, Br, I, OAc or CF3SO3.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the catalyst FeX2-8-OIQ complex is a compound shown in Formula IV, wherein R11, R12, R13, R14, R15, R16 and R17 are H; R10 is C1˜C4 alkyl or diphenylmethylene; R9 is C1˜C4 alkyl, benzyl, phenyl or 2,6-diisopropylphenyl; R18 is C1˜C4 alkyl, benzyl or phenyl; X is Cl or Br.

### Claim 5 (depends on 3)

The method according to claim 3, wherein the FeX2-8-OIQ complex is shown in Formula IV-1 or Formula IV-2,

### Claim 6 (depends on 1)

The method according to claim 1, wherein the silane compound is benzene silane or n-octadecyl silane.

### Claim 7 (depends on 1)

The method according to claim 1, wherein an organic solvent is added to the method, and the organic solvent is any one of benzene, carbon tetrachloride, toluene, tetrahydrofuran, ether, dichloromethane, acetonitrile, dioxane, petroleum ether, cyclohexane, n-hexane, ethyl acetate, chloroform, and dimethylformamide.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the reducing agent is any one of sodium triethylborohydride, sodium tri-sec-butyl-borohydride, lithium triethylborohydride, sodium tert-butoxide, potassium tert-butoxide, lithium tert-butoxide, sodium tert-pentoxide, sodium ethoxide, sodium methoxide and potassium methoxide.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the mole ratio of the disubstituted olefin shown in Formula I, FeX2-8-OIQ complex, silane compound, acetonitrile and reducing agent is 1:0.00001-0.1:0.02-0.2:0.1-0.3:0.06-0.3.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the reaction temperature is 0° C.˜room temperature.
